it has proved to be more effective in low-grade lymphoid malignancies ( chronic leukaemias , indolent lymphomas ) than in more undifferentiated neoplasms ( acute leukaemias , lymphoblastic and immunoblastic lymphomas ) , and is outstandingly effective in hairy cell leukaemia , both as initial therapy and after failure of splenectomy and interferon .
C0023443
hairy cell leukaemia
C0021747
interferon